On Ariad's investor's day, Dr. Frank Haluska was pounding the table on the fact that Ariad wants to enter a first line trial for Pona by the middle of 2012. Now we know why..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.